Literature DB >> 3209844

Prognosis in Sturge-Weber disease: comparison of unihemispheric and bihemispheric involvement.

E M Bebin1, M R Gomez.   

Abstract

One hundred two patients with Sturge-Weber disease who were seen at the Mayo Clinic between 1942 and 1986 were studied retrospectively to determine the difference in prognosis between unihemispheric (88 patients) and bihemispheric (14 patients) involvement. Seizures occurred in 63 with unihemispheric involvement and 13 with bihemispheric; the mean age at onset of seizures was 24 months in the former and 6 months in the latter. Of the total group, 19% were severely or moderately mentally retarded, 27% were mentally retarded but educable, and 45% had average intelligence. In the bihemispheric involvement group, 46% were severely or moderately mentally retarded, 38% were retarded but educable, and only 8% had average intelligence. Bilateral involvement of the brain by Sturge-Weber disease is associated with earlier onset of seizures and worse prognosis for mental development compared with unilateral involvement.

Entities:  

Mesh:

Year:  1988        PMID: 3209844     DOI: 10.1177/088307388800300306

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  14 in total

1.  Magnetic resonance spectroscopic imaging detects abnormalities in normal-appearing frontal lobe of patients with Sturge-Weber syndrome.

Authors:  Carlos E A Batista; Harry T Chugani; Jiani Hu; E Mark Haacke; Michael E Behen; Emily J Helder; Csaba Juhász
Journal:  J Neuroimaging       Date:  2008-07       Impact factor: 2.486

Review 2.  Presentation, diagnosis, pathophysiology, and treatment of the neurological features of Sturge-Weber syndrome.

Authors:  Anne M Comi
Journal:  Neurologist       Date:  2011-07       Impact factor: 1.398

Review 3.  A Multidisciplinary Consensus for Clinical Care and Research Needs for Sturge-Weber Syndrome.

Authors:  Alejandro J De la Torre; Aimee F Luat; Csaba Juhász; Mai Lan Ho; Davis P Argersinger; Kara M Cavuoto; Mabel Enriquez-Algeciras; Stephanie Tikkanen; Paula North; Craig N Burkhart; Harry T Chugani; Karen L Ball; Anna Lecticia Pinto; Jeffrey A Loeb
Journal:  Pediatr Neurol       Date:  2018-04-18       Impact factor: 3.372

4.  Sturge-weber syndrome.

Authors:  Catherine D Bachur; Anne M Comi
Journal:  Curr Treat Options Neurol       Date:  2013-10       Impact factor: 3.598

Review 5.  Updates and future horizons on the understanding, diagnosis, and treatment of Sturge-Weber syndrome brain involvement.

Authors:  Warren Lo; Douglas A Marchuk; Karen L Ball; Csaba Juhász; Lori C Jordan; Joshua B Ewen; Anne Comi
Journal:  Dev Med Child Neurol       Date:  2011-12-23       Impact factor: 5.449

6.  Clinical outcomes in bilateral Sturge-Weber syndrome.

Authors:  Bálint Alkonyi; Harry T Chugani; Samir Karia; Michael E Behen; Csaba Juhász
Journal:  Pediatr Neurol       Date:  2011-06       Impact factor: 3.372

7.  Physical and Family History Variables Associated With Neurological and Cognitive Development in Sturge-Weber Syndrome.

Authors:  Alyssa M Day; Charles E McCulloch; Adrienne M Hammill; Csaba Juhász; Warren D Lo; Anna L Pinto; Daniel K Miles; Brian J Fisher; Karen L Ball; Angus A Wilfong; Alex V Levin; Avrey J Thau; Anne M Comi; Jim I Koenig; Michael T Lawton; Douglas A Marchuk; Marsha A Moses; Sharon F Freedman; Jonathan Pevsner
Journal:  Pediatr Neurol       Date:  2018-12-20       Impact factor: 3.372

8.  Hypothesis: Presymptomatic treatment of Sturge-Weber Syndrome With Aspirin and Antiepileptic Drugs May Delay Seizure Onset.

Authors:  Alyssa M Day; Adrienne M Hammill; Csaba Juhász; Anna L Pinto; E Steve Roach; Charles E McCulloch; Anne M Comi
Journal:  Pediatr Neurol       Date:  2018-11-24       Impact factor: 3.372

Review 9.  [Sturge-Weber syndrome].

Authors:  W Reith; U Yilmaz; A Zimmer
Journal:  Radiologe       Date:  2013-12       Impact factor: 0.635

10.  Anticonvulsant Efficacy in Sturge-Weber Syndrome.

Authors:  Emma H Kaplan; Eric H Kossoff; Catherine D Bachur; Milton Gholston; Jihoon Hahn; Matthew Widlus; Anne M Comi
Journal:  Pediatr Neurol       Date:  2016-01-11       Impact factor: 3.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.